Cosmetic use of poly-l-lactic acid: A retrospective study of 130 patients: Young investigators writing competition winners

Dermatologic Surgery

Volumn 36, Issue 2, 2010, Pages 161-170

  Palm, Melanie D ^a   Woodhall, Katrina E ^a   Butterwick, Kimberly J ^a   Goldman, Mitchel P ^a  

^a Dermatology & Cosmetic Laser Associates of La Jolla   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYLACTIC ACID;

ADULT; AGED; AGING; ARTICLE; BIODEGRADABILITY; CHEEK; FEMALE; HAND; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY; SKIN ATROPHY; SKIN BRUISING; SUBCUTANEOUS NODULE; TREATMENT OUTCOME;

CONTUSIONS; COSMETIC TECHNIQUES; DRUG ERUPTIONS; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; MALE; MIDDLE AGED; PATIENT SATISFACTION; POLYMERS; POPULATION SURVEILLANCE; QUESTIONNAIRES; REJUVENATION; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SKIN AGING;

EID: 76249109446     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2009.01419.x     Document Type: Article

References (30)

1. Hamilton DG, Gauthier N, Robertson BF. Late-onset, recurrent facial nodules associated with injection of poly-l-lactic acid. Dermatol Surg 2008 34 : 123 126.
2. ™. J Drugs Dermatol 2004 3 : 542 547.
3. Vleggaar D. Soft-tissue augmentation and the role of poly-l-lactic acid. Plast Reconstr Surg 2006 118 : 46S 54S.
4. Gogolewski S, Jovanovic M, Perren SM, et al. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxy-butyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993 27 : 1135 1148.
5. Apikian M, Roberts S, Goodman GJ. Adverse reactions to poly-l-lactic acid injection in the peri-orbital area. J Cosmet Dermatol 2007 6 : 95 101.
6. Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-l-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005 52 : 233 239.
7. Keni SP, Sidle DM. Sculptra (injectable poly-l-lactic acid). Facial Plast Surg Clin N Am 2007 15 : 91 7.
8. Narins RS. Minimizing adverse events associated with poly-l-lactic acid injection. Dermatol Surg 2008 34 : S100 4.
9. Ralston JP, Blume JE, Zeitouni NC. Treatment of postoperative soft tissue loss with injectable poly-l-lactic acid. J Drugs Dermatol 2006 5 : 1000 1001.
10. Rendon MI, Keeling J. Poly-l-lactic acid for the treatment of trauma-induced facial lipoatrophy and asymmetry. Cutis 2008 81 : 218 222.
11. Redaelli A. Cosmetic use of polylactic acid for hand rejuvenation: report on 27 patients. J Cosmet Dermatol 2006 5 : 233 238.
12. Beer K. A single-center, open-label study on the use of injectable poly-l-lactic acid for the treatment of moderate to severe scarring from acne or varicella. Dermatol Surg 2007 33 : S159 67.
13. Levy RM, Redbord KP, Hanke CW. Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-l-lactic acid: a prospective 3-year follow-up study. J Am Acad Dermatol 2008 59 : 923 933.
14. Hanke CW, Redbord KP. Safety and efficacy of poly-l-lactic acid in HIV lipoatrophy and lipoatrophy of aging. J Drugs Dermatol 2007 6 : 123 128.
15. Rotunda AM, Narins RS. Poly-l-lactic acid: a new dimension in soft tissue augmentation. Dermatol Ther 2006 19 : 151 158.
16. Engelhard P, Humble G, Mest D. Safety of Sculptra: a review of clinical trial data. J Cosmet Laser Ther 2005 7 : 201 205.
17. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review. Dermatol Surg 2005 31 : 1616 1625.
18. Stewart DB, Morganroth GS, Mooney MA, et al. Management of visible granulomas following periorbital injection of poly-l-lactic acid. Ophthal Plast Reconstr Surg 2007 23 : 298 301.
19. Dayan SH, Antonucci CM, Stephany M. Painful red, hot bumps after injectable poly-l-lactic acid treatment: a case report. Cosmet Dermatol 2008 21 : 388 390.
20. Wolfram D, Tzankov A, Piza-Katzer H. Surgery for foreign body reactions due to injectable fillers. Dermatology 2006 213 : 300 304.
21. Beljaards RC, de Roos KP, Bruins FG. NewFill for skin augmentation: a new filler or failure? Dermatol Surg 2005 31 : 772 776.
22. Woerle B, Hanke CW, Sattler G. Poly-l-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol 2004 3 : 385 389.
23. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: Results of the open-label study VEGA. AIDS 2003 17 : 2471 2477.
24. Moyle GJ, Lysakova L, Brown S, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 2004 5 : 82 7.
25. Mest DR. Safety and efficacy of intradermal poly-l-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy. Antiviral Ther 2004 9 : 36.
26. Sylan Z. Facial fillers and their complications. Aesthet Surg J 2003 23 : 221 224.
27. Lowe NJ. Dispelling the myth: appropriate use of poly-l-lactic acid and clinical considerations. JEADV 2006 20 : S2 6.
28. Weinkle S. Minimizing the risk of adverse events with injectable poly-l-lactic acid. Int J Dermatol 2008 6 : 11.
29. Lam SM, Azizzadeh B, Graivier M. Injectable poly-l-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006 118 : 55S 63S.
30. Lowe NJ. Optimizing poly-l-lactic acid use. J Cosmet Laser Ther 2008 10 : 43 6.